除湿活胃饮治疗脾胃湿热型残胃炎临床观察

Observation of Clinical Efficacy of Chushi Huowei Decoction in Treating Inflammation of Gastric Relict of Spleen-Stomach Damp Heat Type

目的观察除湿活胃饮治疗脾胃湿热型残胃炎的临床疗效及安全性。方法将62例脾胃湿热型残胃炎患者采用随机数字表法随机分为治疗组对照组各31例。对照组口服铝碳酸镁片,治疗组在此基础上加服除湿活胃饮。疗程8周。比较2组临床疗效及胃镜、组织学疗效。结果 2组治疗后中医症状积分均显著下降(P<0.01),治疗组较对照组下降更为明显(P<0.01);治疗组胃镜、组织学疗效均优于对照组(P<0.05,P<0.01)。2组均无明显不良反应。结论除湿活胃饮治疗脾胃湿热型残胃炎安全有效。

Objective To observe the clinical efficacy and safety of Chushi Huowei Decoction in treating inflammation of gastric relict of spleen-stomach damp heat type. Methods Totally 62 patients with inflammation of gastric relict were divided into treatment group and control group with random number table, 31 patients in each group. The control group was given hydrotalcite and the treatment group was treated by adding of Chushi Huowei Decoction. After eight-week treatment, the clinical efficacy, gastric mucosal lesions efficacy, and gastric mucosal pathology efficacy of the two groups were compared. Results Eight-weeks later, traditional Chinese medicine symptom scores of both groups were obviously lower than those before treatment （P〈0.01）. And the decrease in the treatment group was more obvious than that in the control group （P〈0.01）. Curative effects of gastric mucosal lesions and pathologic condition in treatment group were better than those in the control group （P〈0.05, P〈0.01）. Neither groups had any adverse reaction. Conclusion Chushi Huowei Decoction has reliable therapeutic effect and safety in treating inflammation of gastric relict of spleen-stomach damp heat type.